Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1972 1
1984 1
1989 2
1992 3
1993 1
1995 1
1998 3
2005 2
2006 1
2007 2
2008 2
2009 2
2010 4
2011 3
2012 2
2013 7
2014 10
2015 8
2016 8
2017 3
2019 2
2020 8
2021 3
2022 5
Text availability
Article attribute
Article type
Publication date

Search Results

73 results
Results by year
Filters applied: . Clear all
Page 1
COVID-19-neutralizing antibodies predict disease severity and survival.
Garcia-Beltran WF, Lam EC, Astudillo MG, Yang D, Miller TE, Feldman J, Hauser BM, Caradonna TM, Clayton KL, Nitido AD, Murali MR, Alter G, Charles RC, Dighe A, Branda JA, Lennerz JK, Lingwood D, Schmidt AG, Iafrate AJ, Balazs AB. Garcia-Beltran WF, et al. Among authors: murali mr. Cell. 2021 Jan 21;184(2):476-488.e11. doi: 10.1016/j.cell.2020.12.015. Epub 2020 Dec 15. Cell. 2021. PMID: 33412089 Free PMC article.
Clinical sensitivity and interpretation of PCR and serological COVID-19 diagnostics for patients presenting to the hospital.
Miller TE, Garcia Beltran WF, Bard AZ, Gogakos T, Anahtar MN, Astudillo MG, Yang D, Thierauf J, Fisch AS, Mahowald GK, Fitzpatrick MJ, Nardi V, Feldman J, Hauser BM, Caradonna TM, Marble HD, Ritterhouse LL, Turbett SE, Batten J, Georgantas NZ, Alter G, Schmidt AG, Harris JB, Gelfand JA, Poznansky MC, Bernstein BE, Louis DN, Dighe A, Charles RC, Ryan ET, Branda JA, Pierce VM, Murali MR, Iafrate AJ, Rosenberg ES, Lennerz JK. Miller TE, et al. Among authors: murali mr. FASEB J. 2020 Oct;34(10):13877-13884. doi: 10.1096/fj.202001700RR. Epub 2020 Aug 28. FASEB J. 2020. PMID: 32856766 Free PMC article. Clinical Trial.
SARS-CoV-2-specific ELISA development.
Roy V, Fischinger S, Atyeo C, Slein M, Loos C, Balazs A, Luedemann C, Astudillo MG, Yang D, Wesemann DR, Charles R, Lafrate AJ, Feldman J, Hauser B, Caradonna T, Miller TE, Murali MR, Baden L, Nilles E, Ryan E, Lauffenburger D, Beltran WG, Alter G. Roy V, et al. Among authors: murali mr. J Immunol Methods. 2020 Sep-Oct;484-485:112832. doi: 10.1016/j.jim.2020.112832. Epub 2020 Aug 8. J Immunol Methods. 2020. PMID: 32780998 Free PMC article.
Evolving immunological frontiers in tuberculosis.
Murali MR, Vedanthan PK. Murali MR, et al. Indian J Tuberc. 2015 Jul;62(3):139-42. doi: 10.1016/j.ijtb.2015.09.009. Epub 2015 Nov 4. Indian J Tuberc. 2015. PMID: 26600324 Review. No abstract available.
Serum free light chain analysis.
Davids MS, Murali MR, Kuter DJ. Davids MS, et al. Among authors: murali mr. Am J Hematol. 2010 Oct;85(10):787-90. doi: 10.1002/ajh.21815. Am J Hematol. 2010. PMID: 20721885 Free article. Review.
High Seroprevalence of Anti-SARS-CoV-2 Antibodies in Chelsea, Massachusetts.
Naranbhai V, Chang CC, Beltran WFG, Miller TE, Astudillo MG, Villalba JA, Yang D, Gelfand J, Bernstein BE, Feldman J, Hauser BM, Caradonna TM, Alter G, Murali MR, Jasrasaria R, Quinlan J, Xerras DC, Betancourt JR, Louis DN, Schmidt AG, Lennerz J, Poznansky MC, Iafrate AJ. Naranbhai V, et al. Among authors: murali mr. J Infect Dis. 2020 Nov 13;222(12):1955-1959. doi: 10.1093/infdis/jiaa579. J Infect Dis. 2020. PMID: 32906151 Free PMC article.
COVID-19 neutralizing antibodies predict disease severity and survival.
Garcia-Beltran WF, Lam EC, Astudillo MG, Yang D, Miller TE, Feldman J, Hauser BM, Caradonna TM, Clayton KL, Nitido AD, Murali MR, Alter G, Charles RC, Dighe A, Branda JA, Lennerz JK, Lingwood D, Schmidt AG, Iafrate AJ, Balazs AB. Garcia-Beltran WF, et al. Among authors: murali mr. medRxiv. 2020 Oct 20:2020.10.15.20213512. doi: 10.1101/2020.10.15.20213512. Preprint. medRxiv. 2020. PMID: 33106822 Free PMC article. Updated.
Genotoxicity evaluation of medical devices: A regulatory perspective.
Kumaravel TS, Sathya TN, Balaje R, Pradeepa P, Yogaraj D, Murali MR, Navaneethakrishnan KR, Murugan S, Jha AN. Kumaravel TS, et al. Among authors: murali mr. Mutat Res Rev Mutat Res. 2022 Jan-Jun;789:108407. doi: 10.1016/j.mrrev.2021.108407. Epub 2021 Nov 30. Mutat Res Rev Mutat Res. 2022. PMID: 35690410 Review.
Practical management of suspected hypersensitivity reactions to anti-tuberculosis drugs.
Bermingham WH, Bhogal R, Arudi Nagarajan S, Mutlu L, El-Shabrawy RM, Madhan R, Krishnaswamy UM, Murali MR, Kudagammana ST, Shrestha R, Sumantri S, Christopher DJ, Mahesh PA, Dedicoat M, Krishna MT. Bermingham WH, et al. Among authors: murali mr. Clin Exp Allergy. 2022 Mar;52(3):375-386. doi: 10.1111/cea.14084. Epub 2022 Jan 20. Clin Exp Allergy. 2022. PMID: 34939251 Review.
73 results